ACCELRYS AND SUN MICROSYSTEMS EXTEND ALLIANCE TO OPTIMIZE DISCOVERY STUDIO[tm] TO J2EE[tm] TECHNOLOGY STANDARD

3/13/2002 - Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (NASDAQ: PCOP), and Sun Microsystems, Inc. today announced the expansion of their long-standing alliance in the life sciences market to jointly support the development of Discovery Studio, Accelrys' forthcoming platform for accelerating pre-clinical drug research. Discovery Studio will be based on Sun's Java[tm] 2 Platform, Enterprise Edition (J2EE[tm]) technology standard, with both companies contributing to the design and certification to ensure its adherence to these standards. By delivering to the market a solution based on open standards, Accelrys and Sun are helping to increase ease of adoption, integration and interoperability with third-party and in-house informatics and data management solutions.

Previous Page | News by Category | News Search

If you found this page useful, bookmark and share it on: